Education
About Us
Working with TipRanks
Follow Us
Laekna, Inc. (HK:2105)
:2105
2105 Stock Chart & Stats
HK$14.00
-HK$0.72(-6.22%)
At close: 4:00 PM EST
HK$14.00
-HK$0.72(-6.22%)
Day’s Range― - ―
52-Week RangeHK$8.10 - HK$23.50
Previous CloseN/A
Volume9.24M
Average Volume (3M)5.64M
Market Cap
HK$5.87B
Enterprise ValueHK$5.86B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding446,466,340
10 Day Avg. Volume2,639,970
30 Day Avg. Volume5,642,659
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$24.16Price Target Upside72.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical TrialsCompletion of LAE102's phase 1 clinical trial may attract licensing interest from Eli Lilly and other global players.
Financial StabilityNet cash on hand can sustain operations for around 3 years, providing financial stability.
Strategic PartnershipsEli Lilly is likely to license in Laekna's LAE102 for muscle loss prevention, enhancing strategic collaborations.
Bears Say
Laekna, Inc. News
2105 FAQ
What was Laekna, Inc.’s price range in the past 12 months?
Laekna, Inc. lowest stock price was HK$8.10 and its highest was HK$23.50 in the past 12 months.
What is Laekna, Inc.’s market cap?
Laekna, Inc.’s market cap is HK$5.87B.
When is Laekna, Inc.’s upcoming earnings report date?
Laekna, Inc.’s upcoming earnings report date is Mar 31, 2026 which is in 92 days.
How were Laekna, Inc.’s earnings last quarter?
Laekna, Inc. released its earnings results on Aug 13, 2025. The company reported -HK$0.381 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.381.
Is Laekna, Inc. overvalued?
According to Wall Street analysts Laekna, Inc.’s price is currently Undervalued.
Does Laekna, Inc. pay dividends?
Laekna, Inc. does not currently pay dividends.
What is Laekna, Inc.’s EPS estimate?
Laekna, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Laekna, Inc. have?
Laekna, Inc. has 446,466,340 shares outstanding.
What happened to Laekna, Inc.’s price movement after its last earnings report?
Laekna, Inc. reported an EPS of -HK$0.381 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.371%.
Which hedge fund is a major shareholder of Laekna, Inc.?
Currently, no hedge funds are holding shares in HK:2105
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Laekna, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
90.09%
12-Months-Change
Fundamentals
Return on Equity
-34.39%
Trailing 12-Months
Asset Growth
14.20%
Trailing 12-Months
2105 Stock 12 Month Forecast
Average Price Target
HK$24.16
▲(72.57% Upside)
Technical Analysis
Kindstar Globalgene Technology, Inc.
―
Ocumension Therapeutics
―
TOT BIOPHARM International Co. Ltd.
―
Lepu Biopharma Co. Ltd. Class H
―
Broncus Holding Corp.
―
Options Prices
Currently, No data available
---